Provided by Tiger Trade Technology Pte. Ltd.

Immuneering Corp

5.30
+0.05000.95%
Post-market: 5.24-0.0600-1.13%19:50 EDT
Volume:445.57K
Turnover:2.38M
Market Cap:342.22M
PE:-5.41
High:5.43
Open:5.31
Low:5.28
Close:5.25
52wk High:10.08
52wk Low:3.86
Shares:64.57M
Float Shares:49.21M
Volume Ratio:0.81
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9796
EPS(LYR):-1.2729
ROE:-52.15%
ROA:-32.77%
PB:1.79
PE(LYR):-4.16

Loading ...

aTyr Pharma Q2 Net Loss Narrows

Reuters
·
Aug 08

Canada's Xenon Pharma Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 07

HC Wainwright Initiates Immuneering at Buy With $14 Price Target

MT Newswires Live
·
Aug 06

Immuneering Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 06

Immuneering Corporation : H.c. Wainwright Initiates Coverage with Buy Rating

THOMSON REUTERS
·
Aug 06

Arcus Biosciences Q2 Revenue Falls Sharply on Lower License Income

Reuters
·
Aug 06

Tenaya Therapeutics Q2 Net Loss Widens on Impairment Charge

Reuters
·
Aug 06

Biopharma Firm Xencor's Q2 Revenue Beats on Royalty Revenue, Milestone Payments

Reuters
·
Aug 06

Black Diamond Therapeutics Q2 Net Loss Narrows Year over Year

Reuters
·
Aug 06

Immuneering Expects Cash Runway to Fund Operations into 2029

Reuters
·
Aug 05

Immuneering Q2 EPS $(0.27), Inline

Benzinga Earnings
·
Aug 05

Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates

THOMSON REUTERS
·
Aug 05

Immuneering publishes preclinical data on atebimetinib in Cancer Research

TIPRANKS
·
Jul 22

Immuneering Flags New Press Release on Atebimetinib Preclinical Study Publication in Cancer Research

Reuters
·
Jul 22

Immuneering Corp : Needham Raises Target Price to $18 from $11

THOMSON REUTERS
·
Jul 20

Immuneering is Maintained at Buy by Needham

Dow Jones
·
Jul 20

Immuneering Corporation Announces Grants of Inducement Awards

GlobeNewswire
·
Jul 18

Immuneering CFO Andrew Gengos Files Initial Beneficial Ownership Statement

Reuters
·
Jul 17

Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX), Vera Therapeutics (VERA) and Alnylam Pharma (ALNY)

TIPRANKS
·
Jul 13

Immuneering Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Jul 08